Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T N Chase

Showing results (111-120 of 397) with videos related to

Pageof 40
Sort By:
Neurology|September 1, 1972
Down's syndrome. Central monoamine turnover in patients with diminished platelet serotoninI T Lott, D L Murphy, T N Chase
Pediatric Research|September 1, 1972
Down's syndrome: transport, storage, and metabolism of serotonin in blood plateletsI T Lott, T N Chase, D L Murphy
Psychopharmacology. Supplementum|January 1, 1985
GABA dysfunction in the pathophysiology of tardive dyskinesiaC A Tamminga, G K Thaker, T N Chase
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1993
Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesionsR C Boldry, T N Chase, T M Engber
Lancet (London, England)|June 16, 1973
Sustained-release levodopaA C Woods, G A Glaubiger, T N Chase
Archives of Neurology|April 1, 1985
Cholecystokinin and neurotensin gradients in human CSFC A Tamminga, P A LeWitt, T N Chase
Brain Research|August 21, 1992
Differential effect of subthalamic nucleus ablation on dopamine D1 and D2 agonist-induced rotation in 6-hydroxydopamine-lesioned ratsJ J Anderson, T N Chase, T M Engber
Annals of the New York Academy of Sciences|January 1, 1988
Mesocortical dopaminergic function and human cognitionD R Weinberger, K F Berman, T N Chase
Brain Research|March 17, 2000
NMDA and non-NMDA receptor-stimulated IkappaB-alpha degradation: differential effects of the caspase-3 inhibitor DEVD.CHO, ethanol and free radical scavenger OPC-14117M Nakai, Z Qin, Y Wang, et al.
Clinical Neuropharmacology|April 1, 1992
Glutamatergic therapy of Huntington's choreaM E Giuffra, M M Mouradian, T N Chase
Pageof 40

Showing results (111-120 of 397) with videos related to

Sort By:
Pageof 40
Neurology|September 1, 1972
Down's syndrome. Central monoamine turnover in patients with diminished platelet serotoninI T Lott, D L Murphy, T N Chase
Pediatric Research|September 1, 1972
Down's syndrome: transport, storage, and metabolism of serotonin in blood plateletsI T Lott, T N Chase, D L Murphy
Psychopharmacology. Supplementum|January 1, 1985
GABA dysfunction in the pathophysiology of tardive dyskinesiaC A Tamminga, G K Thaker, T N Chase
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1993
Influence of previous exposure to levodopa on the interaction between dizocilpine and dopamine D1 and D2 agonists in rats with 6-hydroxydopamine-induced lesionsR C Boldry, T N Chase, T M Engber
Lancet (London, England)|June 16, 1973
Sustained-release levodopaA C Woods, G A Glaubiger, T N Chase
Archives of Neurology|April 1, 1985
Cholecystokinin and neurotensin gradients in human CSFC A Tamminga, P A LeWitt, T N Chase
Brain Research|August 21, 1992
Differential effect of subthalamic nucleus ablation on dopamine D1 and D2 agonist-induced rotation in 6-hydroxydopamine-lesioned ratsJ J Anderson, T N Chase, T M Engber
Annals of the New York Academy of Sciences|January 1, 1988
Mesocortical dopaminergic function and human cognitionD R Weinberger, K F Berman, T N Chase
Brain Research|March 17, 2000
NMDA and non-NMDA receptor-stimulated IkappaB-alpha degradation: differential effects of the caspase-3 inhibitor DEVD.CHO, ethanol and free radical scavenger OPC-14117M Nakai, Z Qin, Y Wang, et al.
Clinical Neuropharmacology|April 1, 1992
Glutamatergic therapy of Huntington's choreaM E Giuffra, M M Mouradian, T N Chase
Pageof 40